Scarica l'app Stockscreener
83.38
0.36%
0.30
Dopo l'orario di chiusura:
83.80
0.42
+0.50%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché EW Giù?
Forum
Previsione
Frazionamento azionario
Edwards Lifesciences Corp Borsa (EW) Ultime notizie
Global Interventional Cardiology Devices Market is Predicted to Cross ~USD 30 Billion by 2034, Due to the Rising Cardiovascular Disease Burden | DelveInsight - GlobeNewswire Inc.
Edwards Lifesciences Resolves $140 Million Harpoon Medical Case - Bloomberg Law News
Edwards Lifesciences Completes Key Study on SAPIEN XT THV - TipRanks
Squarepoint Ops LLC Acquires 50,924 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Is There Now An Opportunity In Edwards Lifesciences Corporation (NYSE:EW)? - Yahoo Finance
Holocene Advisors LP Buys 1,223,460 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
934,449 Shares in Edwards Lifesciences Corporation $EW Bought by Hudson Bay Capital Management LP - MarketBeat
Hudson Bay Capital Management LP Invests $73.08 Million in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (NYSE:EW) VP Donald Bobo Jr Sells 11,386 Shares - MarketBeat
Elevatus Welath Management Makes New Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Bellevue Group AG Sells 82,892 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Banque Transatlantique SA Purchases 24,575 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Insider Sell: Heisz Stone Sells Shares of Edwards Lifesciences C - GuruFocus
Nebula Research & Development LLC Sells 16,819 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Purchased by DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main - MarketBeat
Edwards Lifesciences (NYSE:EW) VP Sells 11,340 Shares - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Glenview Trust co - MarketBeat
Citigroup Adjusts Edwards Lifesciences Price Target to $101 From $96, Maintains Buy Rating - marketscreener.com
State Street Corp Cuts Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Insider Sold Shares Worth $2,153,373, According to a Recent SEC Filing - marketscreener.com
Daiwa Securities Group Inc. Acquires 24,475 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Bank of Nova Scotia Grows Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Transcript : Edwards Lifesciences CorporationAnalyst/Investor Day - marketscreener.com
Scott Ullem Sells 7,700 Shares of Edwards Lifesciences (NYSE:EW) Stock - MarketBeat
Vega Investment Solutions Has $28,000 Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Purchased by Natixis - MarketBeat
Edwards Lifesciences Corporation $EW Shares Acquired by Ossiam - MarketBeat
Edwards Lifesciences’ Markowitz sells $50k in stock By Investing.com - Investing.com Canada
Edwards Lifesciences Corporation $EW Stock Position Increased by 2Xideas AG - MarketBeat
Edwards Lifesciences’ Markowitz sells $50k in stock - Investing.com
Barclays Raises Edwards Lifesciences (EW) Price Target to $103.0 - GuruFocus
Leerink Partners Adjusts Edwards Lifesciences PT to $87 From $88, Maintains Market Perform Rating - marketscreener.com
WINTON GROUP Ltd Acquires 43,197 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences stock price target raised to $95 from $90 at Bernstein - Investing.com
Invesco Ltd. Decreases Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (NYSE:EW) Reaches New 12-Month High Following Analyst Upgrade - MarketBeat
Edwards Lifesciences (NYSE:EW) Price Target Raised to $100.00 at Royal Bank Of Canada - MarketBeat
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says - MarketBeat
Epoch Investment Partners Inc. Has $20.45 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (EW): Stifel Raises Price Target to $100 | - GuruFocus
Edwards Lifesciences (EW) Sees Analyst Target Price Increase Tod - GuruFocus
Amundi Raises Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
UBS Maintains Neutral Rating on Edwards Lifesciences (EW) and Ra - GuruFocus
Wells Fargo Maintains Edwards Lifesciences (EW) Overweight Recommendation - Nasdaq
Will Edwards Lifesciences’ (EW) Upgraded 2025–2026 Outlook Reshape Its Long-Term Growth Narrative? - Yahoo Finance
Edwards Lifesciences (EW) Analyst Rating Update for December 5, 2025 | EW Stock News - GuruFocus
Edwards Lifesciences (EW): Reassessing Valuation After Upbeat 2025–2026 Outlook and TAVR Growth Signals - Yahoo Finance
Edwards Lifesciences Sets Cautious Targets Yet Keeps Investors Interested - Finimize
Edwards Lifesciences : EW 2025 IC FINAL - marketscreener.com
Bernstein Adjusts Edwards Lifesciences Price Target to $95 From $90, Maintains Market Perform Rating - marketscreener.com
Wells Fargo Adjusts Price Target for Edwards Lifesciences (EW) | - GuruFocus
Edwards Lifesciences' Long-term Business Outlook Appears Achievable, RBC Says - marketscreener.com
Edwards Lifesciences Bags Prosthetic Valve Patent In EU - Law360
Truist Securities Raises Price Target for Edwards Lifesciences (EW) | EW Stock News - GuruFocus
How Do Investors Really Feel About Edwards Lifesciences Corp? - Benzinga
Edwards Lifesciences stock hits 52-week high at 87.42 USD By Investing.com - Investing.com Nigeria
Edwards Lifesciences stock hits 52-week high at 87.42 USD - Investing.com
Raymond James Adjusts PT on Edwards Lifesciences to $100 From $96, Maintains Outperform Rating - marketscreener.com
UBS Adjusts Price Target on Edwards Lifesciences to $92 From $90, Maintains Neutral Rating - marketscreener.com
Edwards Lifesciences price target raised to $92 from $90 at UBS - Investing.com
RBC Capital raises Edwards Lifesciences stock price target to $100 on 2026 outlook - Investing.com
Truist Securities Adjusts PT on Edwards Lifesciences to $92 From $90, Maintains Hold Rating - marketscreener.com
Edwards Lifesciences price target raised to $100 from $95 at Stifel - TipRanks
RBC Raises Price Target on Edwards Lifesciences to $100 From $95, Keeps Outperform Rating - marketscreener.com
Stifel Adjusts Price Target on Edwards Lifesciences to $100 From $95, Maintains Buy Rating - marketscreener.com
Wells Fargo Adjusts Price Target on Edwards Lifesciences to $96 From $95, Maintains Overweight Rating - marketscreener.com
0.58%
1.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):